BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11165194)

  • 1. Various forms of plasma cysteine and its metabolites in patients undergoing hemodialysis.
    Wlodek PJ; Iciek MB; Milkowski A; Smolenski OB
    Clin Chim Acta; 2001 Feb; 304(1-2):9-18. PubMed ID: 11165194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of nutritional status on plasma and erythrocyte sulphur amino acids, sulph-hydryls, and inorganic sulphate in end-stage renal disease.
    Suliman ME; Bárány P; Divino Filho JC; Qureshi AR; Stenvinkel P; Heimbürger O; Anderstam B; Lindholm B; Bergström J
    Nephrol Dial Transplant; 2002 Jun; 17(6):1050-6. PubMed ID: 12032196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma aminothiol oxidation in chronic hemodialysis patients.
    Himmelfarb J; McMenamin E; McMonagle E
    Kidney Int; 2002 Feb; 61(2):705-16. PubMed ID: 11849414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered plasma free and protein-bound sulfur amino acid levels in patients undergoing maintenance hemodialysis.
    Smolin LA; Laidlaw SA; Kopple JD
    Am J Clin Nutr; 1987 Apr; 45(4):737-43. PubMed ID: 3565301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole blood-, plasma- and red blood cell glutathione and cysteine in patients with kidney disease and during hemodialysis.
    Jacobson SH; Moldéus P
    Clin Nephrol; 1994 Sep; 42(3):189-92. PubMed ID: 7994938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].
    Olszewska M
    Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced, free and total fractions of homocysteine and other thiol compounds in plasma from patients with renal failure.
    Hultberg B; Andersson A; Arnadottir M
    Nephron; 1995; 70(1):62-7. PubMed ID: 7617118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free cysteine is increased in plasma from hemodialysis patients.
    Nakanishi T; Hasuike Y; Otaki Y; Hama Y; Nanami M; Miyagawa K; Moriguchi R; Nishikage H; Izumi M; Takamitsu Y
    Kidney Int; 2003 Mar; 63(3):1137-40. PubMed ID: 12631098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma sulfate concentration and hyperhomocysteinemia in hemodialysis patients.
    Brunetti M; Terracina L; Timio M; Saronio P; Capodicasa E
    J Nephrol; 2001; 14(1):27-31. PubMed ID: 11281340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysteine Metabolism and Oxidative Processes in the Rat Liver and Kidney after Acute and Repeated Cocaine Treatment.
    Kowalczyk-Pachel D; Iciek M; Wydra K; Nowak E; Górny M; Filip M; Włodek L; Lorenc-Koci E
    PLoS One; 2016; 11(1):e0147238. PubMed ID: 26808533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione and riboflavin status in supplemented patients undergoing home nocturnal hemodialysis versus standard hemodialysis.
    Kannampuzha J; Donnelly SM; McFarlane PA; Chan CT; House JD; Pencharz PB; Darling PB
    J Ren Nutr; 2010 May; 20(3):199-208. PubMed ID: 19913440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of thiol homeostasis in plasma of terminal renal failure patients.
    Włodek PJ; Smolenski OB; Chwatko G; Iciek MB; Miłkowski A; Bald E; Włodek L
    Clin Chim Acta; 2006 Apr; 366(1-2):137-45. PubMed ID: 16337615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiol levels, protein carbonylation and anaerobic sulfur metabolism in erythrocytes of peritoneal dialysis and predialysis patients.
    Włodek P; Marcykiewicz B; Iciek M; Suliga M; Smoleński O; Kowalczyk-Pachel D
    Nephrology (Carlton); 2010 Dec; 15(8):755-61. PubMed ID: 21175961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total, free, and protein-bound thiols in plasma of peritoneal dialysis and predialysis patients.
    Przemysław W; Piotr K; Grażyna C; Danuta KP; Małgorzata I; Bernadeta M; Małgorzata S; Witold S
    Int Urol Nephrol; 2011 Dec; 43(4):1201-9. PubMed ID: 21327523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of serum albumin reductivity in patients with renal dysfunction: a comparison between conservative renal failure patients and hemodialysis patients].
    Suzuki Y; Aoki Y; Matsuyama Y; Hasegawa H; Shinohara Y; Hashimoto T; Era S; Soejima A
    Nihon Jinzo Gakkai Shi; 2008; 50(4):513-20. PubMed ID: 18546883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
    Sjöberg B; Anderstam B; Suliman M; Alvestrand A
    Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma cysteine, cystine, and glutathione in cirrhosis.
    Chawla RK; Lewis FW; Kutner MH; Bate DM; Roy RG; Rudman D
    Gastroenterology; 1984 Oct; 87(4):770-6. PubMed ID: 6468868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of total, free and protein bound thiols as well as sulfane sulfur in different age groups of rats.
    Iciek M; Chwatko G; Lorenc-Koci E; Bald E; Włodek L
    Acta Biochim Pol; 2004; 51(3):815-24. PubMed ID: 15448741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy.
    Suliman ME; Stenvinkel P; Heimbürger O; Bàràny P; Lindholm B; Bergström J
    Am J Kidney Dis; 2002 Sep; 40(3):480-8. PubMed ID: 12200798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients.
    Ross EA; Koo LC; Moberly JB
    Am J Kidney Dis; 1997 Oct; 30(4):489-94. PubMed ID: 9328362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.